These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29141885)

  • 1. A role for bacterial urease in gut dysbiosis and Crohn's disease.
    Ni J; Shen TD; Chen EZ; Bittinger K; Bailey A; Roggiani M; Sirota-Madi A; Friedman ES; Chau L; Lin A; Nissim I; Scott J; Lauder A; Hoffmann C; Rivas G; Albenberg L; Baldassano RN; Braun J; Xavier RJ; Clish CB; Yudkoff M; Li H; Goulian M; Bushman FD; Lewis JD; Wu GD
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Adherent-invasive
    Zhilu X; Xiangqian D; Keli Y; Caroline C; Jingwan Z; Yu L; Tao Z; Cheung CL; Yang S; Fengrui Z; Kl CF; Jy SJ; Jun Y; Anthony B; Nicolas B; Jean-Frédéric C; Sunny Hei W; Yinglei M; Siew C N
    Gut Microbes; 2021; 13(1):1994833. PubMed ID: 34812117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiotic microbiota interactions in Crohn's disease.
    Caparrós E; Wiest R; Scharl M; Rogler G; Gutiérrez Casbas A; Yilmaz B; Wawrzyniak M; Francés R
    Gut Microbes; 2021; 13(1):1949096. PubMed ID: 34313550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiotic gut microbiome: A key element of Crohn's disease.
    Øyri SF; Műzes G; Sipos F
    Comp Immunol Microbiol Infect Dis; 2015 Dec; 43():36-49. PubMed ID: 26616659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperbaric oxygen therapy ameliorates intestinal and systematic inflammation by modulating dysbiosis of the gut microbiota in Crohn's disease.
    Li Y; Sun R; Lai C; Liu K; Yang H; Peng Z; Xu D; Huang F; Tang K; Peng Y; Liu X
    J Transl Med; 2024 May; 22(1):518. PubMed ID: 38816750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial assimilatory sulfate reduction-mediated H
    Luo W; Zhao M; Dwidar M; Gao Y; Xiang L; Wu X; Medema MH; Xu S; Li X; Schäfer H; Chen M; Feng R; Zhu Y
    Microbiome; 2024 Aug; 12(1):152. PubMed ID: 39152482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn's disease.
    Feng L; Zhou N; Li Z; Fu D; Guo Y; Gao X; Liu X
    FASEB J; 2022 Jan; 36(1):e22100. PubMed ID: 34939244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of exclusive enteral nutrition on the gut microbiome and bile acid metabolism in pediatric Crohn's disease.
    Lv Y; Lou Y; Liu A; Cheng Q; Yang G; Xu C; Luo Y; Lou J; Yu J; Fang Y; Zhao H; Peng K; Ni Y; Chen J
    Clin Nutr; 2023 Feb; 42(2):116-128. PubMed ID: 36527826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique β-Glucuronidase Locus in Gut Microbiomes of Crohn's Disease Patients and Unaffected First-Degree Relatives.
    Gloux K; Anba-Mondoloni J
    PLoS One; 2016; 11(1):e0148291. PubMed ID: 26824357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.
    Quévrain E; Maubert MA; Michon C; Chain F; Marquant R; Tailhades J; Miquel S; Carlier L; Bermúdez-Humarán LG; Pigneur B; Lequin O; Kharrat P; Thomas G; Rainteau D; Aubry C; Breyner N; Afonso C; Lavielle S; Grill JP; Chassaing G; Chatel JM; Trugnan G; Xavier R; Langella P; Sokol H; Seksik P
    Gut; 2016 Mar; 65(3):415-425. PubMed ID: 26045134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts.
    Lewis JD; Daniel SG; Li H; Hao F; Patterson AD; Hecht AL; Brensinger CM; Wu GD; Bittinger K; ;
    Cell Mol Gastroenterol Hepatol; 2024; 18(3):101357. PubMed ID: 38750900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
    Sartor RB; Wu GD
    Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids.
    Wang S; Martins R; Sullivan MC; Friedman ES; Misic AM; El-Fahmawi A; De Martinis ECP; O'Brien K; Chen Y; Bradley C; Zhang G; Berry ASF; Hunter CA; Baldassano RN; Rondeau MP; Beiting DP
    Microbiome; 2019 Aug; 7(1):126. PubMed ID: 31472697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses.
    Tyakht AV; Manolov AI; Kanygina AV; Ischenko DS; Kovarsky BA; Popenko AS; Pavlenko AV; Elizarova AV; Rakitina DV; Baikova JP; Ladygina VG; Kostryukova ES; Karpova IY; Semashko TA; Larin AK; Grigoryeva TV; Sinyagina MN; Malanin SY; Shcherbakov PL; Kharitonova AY; Khalif IL; Shapina MV; Maev IV; Andreev DN; Belousova EA; Buzunova YM; Alexeev DG; Govorun VM
    BMC Genomics; 2018 Dec; 19(1):968. PubMed ID: 30587114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of Escherichia-Shigella in Gut Microbiome and Its Potential Correlation with Elevated Level of Plasma Tumor Necrosis Factor Alpha in Patients with Tuberculous Meningitis.
    Li S; Guo J; Liu R; Zhang F; Wen S; Liu Y; Ren W; Zhang X; Shang Y; Gao M; Lu J; Pang Y
    Microbiol Spectr; 2022 Dec; 10(6):e0192622. PubMed ID: 36350161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay.
    Abenavoli L; Giubilei L; Procopio AC; Spagnuolo R; Luzza F; Boccuto L; Scarpellini E
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.